海翔药业(002099) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥405,637,503.30, a decrease of 15.53% compared to ¥480,189,638.76 in the same period last year[2] - The net profit attributable to shareholders for Q3 2024 was a loss of ¥26,122,738.76, an improvement of 54.77% from a loss of ¥57,759,934.00 in Q3 2023[2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥12,461,718.23, which is 64.28% better than the loss of ¥36,881,146.60 in the same period last year[2] - The basic earnings per share for Q3 2024 was -¥0.01, improving by 66.67% from -¥0.03 in Q3 2023[2] - The net profit for Q3 2024 was CNY 10,234,312.62, a significant improvement compared to a net loss of CNY 39,479,339.51 in the same period last year[16] - The company reported a total comprehensive income of CNY 10,234,312.62, contrasting with a total comprehensive loss of CNY 39,479,339.51 in the prior year[17] - Earnings per share for Q3 2024 were CNY 0.01, recovering from a loss of CNY 0.02 per share in the same quarter last year[17] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥139,496,057.94, down 43.60% from ¥247,336,979.19 in the previous year[2] - The cash flow from operating activities generated a net amount of CNY 139,496,057.94, compared to CNY 247,336,979.19 in the previous year, indicating a decrease of about 43.7%[18] - The cash and cash equivalents at the end of the period stood at CNY 1,208,719,421.78, down from CNY 1,641,324,262.76 at the end of the previous year[19] - The company incurred a net cash outflow from investing activities of CNY -105,302,774.39, an improvement from a larger outflow of CNY -133,352,836.53 in the previous year[19] - The cash flow from financing activities showed a net outflow of CNY -88,619,934.53, compared to a net inflow of CNY 462,600,239.98 in the same period last year[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥7,609,930,860.16, reflecting a 1.19% increase from ¥7,520,092,953.12 at the end of the previous year[2] - The total assets of the company reached CNY 7,609,930,860.16, an increase from CNY 7,520,092,953.12, representing a growth of 1.2%[14] - Total liabilities increased to CNY 2,149,395,440.30 from CNY 1,918,372,193.94, marking a rise of 12.0%[14] - The equity attributable to shareholders decreased by 2.49% to ¥5,466,912,403.08 from ¥5,606,352,298.36 at the end of the previous year[2] Operational Metrics - The company reported a significant increase in prepayments, which rose by 141.05% to ¥53,713,839.74 due to increased material payments[6] - The company has seen a 48.08% increase in construction in progress, amounting to ¥552,199,663.53, attributed to increased project investments during the period[6] - Accounts payable increased by 569.29% to 239,998,846.96, mainly due to an increase in issued commercial acceptance bills[7] - The company's financial liabilities decreased by 80.52% to 7,083,613.52, primarily due to an increase in the delivery of foreign exchange derivatives[7] - The company's cash and cash equivalents increased to CNY 1,476,603,702.63 from CNY 1,420,570,794.77, reflecting a growth of 3.9%[12] - Accounts receivable decreased to CNY 368,435,006.58 from CNY 424,703,017.66, a decline of 13.3%[12] - Inventory rose to CNY 800,680,210.22, up 14.0% from CNY 702,270,769.40[12] Income and Expenses - Total operating revenue for the third quarter was CNY 1,444,477,964.62, a decrease of 14.0% compared to CNY 1,676,630,297.77 in the same period last year[15] - Total operating costs amounted to CNY 1,375,713,221.67, down 17.0% from CNY 1,659,118,871.86 year-on-year[15] - The company's financial expenses decreased by 53.46% to -25,483,564.08, mainly due to reduced foreign exchange gains and interest income[7] - The company reported a decrease in financial expenses, with a net financial cost of -CNY 25,483,564.08 compared to -CNY 54,753,678.39 in the previous year[15] - Investment income rose by 111.00% to 6,755,798.04, mainly due to last year's foreign exchange derivative losses[7] - The company reported a significant increase in other income, which rose by 6028.47% to 2,047,127.06, primarily from the disposal of fixed assets[7] - The company recorded an asset impairment loss of -93,574,540.94, primarily due to inventory write-downs[7] - The total assets impairment loss was CNY -93,574,540.94, indicating challenges in asset valuation during the quarter[16] Shareholder Information - The company repurchased 31,478,531 shares, accounting for 1.94% of the total share capital[9] - The total number of ordinary shareholders at the end of the reporting period was 27,682[8] - The actual controller of the company holds a total of 642,782,587 shares, representing a significant ownership stake[9]